Gluten-Free Labeling Under the Current Food Allergen Labeling and Consumer Protection Act (FALCPA) of 2004 and Beyond
January 10, 2013 - Palo Alto CA US
This webinar on gluten-free labeling will detail the efforts made by the USFDA pursuant to the obligations mandated by the Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA). It will show how foods manufacturers and labelers may use the term “gluten-free” in product labeling and what this distinction means. This webinar will highlight the Agency’s action with respect to developing gluten-free regulations and the current status of these requirements. Why Should You Attend: Recent federally-adopted requirements mandate the declaration of major food allergens, as defined by FALCPA. While these requirements mandate FDA’s action in the area of gluten-free labeling, and despite the activity in this area, the Agency has had difficulty in adopting a final rule to date. However, this difficulty does not necessarily prevent the FDA from using other regulatory tools, such as the misbranding provisions, to limit the use of “gluten-free” in food labeling. Thus, it is important for manufacturers and labelers to be aware of the meaning attached to “gluten-free,” including how and when this distinction may be used. This session is designed for food manufacturers and labelers and is focused towards helping both domestic and foreign entities in ensuring compliance with FDA regulations. This session will cover the requirements of FALCPA, particularly in the context of gluten-free labeling, and will highlight FDA action taken to date in this area. Areas Covered in the Webinar: Brief overview of FALCPA, highlighting provisions pertaining to gluten-free labeling. Overview of the products subject to FALCPA and FDA’s gluten-free requirements – including those foods prohibited from using the declaration in product labeling. Examination of how the FDA defines the term “gluten-free”. How to properly declare gluten free foods in labeling, including recognized synonyms of the term. Regulatory status of the gluten-free declaration and timeline of Agency action What FDA expects from manufacturers and labelers. How failure to comply with the guidelines may affect the manufacturing unit.